Market closedRefreshes 15sData NSENot investment advice
TV Chart
128.17
3.78+3.04%
DAY123
₹128.17
130
52W69
₹128.17
133
Open127.48
Prev Close124.39
Bid128.14460
Ask128.20288
Volume1.2M51%vs 20D avg
Market Cap₹806.77 Cr
Promoter Hold.71.29%
Face Value₹5
Fwd P/E
PEG
EV/EBITDA15.76
P/S5.03
ROA
Beta
Div Payout
Valuation

Gaudium IVF and Women Health Ltd valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Gaudium IVF and Women Health Ltd, framed against the sector median so the premium or discount is obvious at a glance.

Gaudium IVF and Women Health Ltd trades at a P/E of 33.66× and P/B of 5.41×.

Key MetricsLive · as of 27 Apr 2026
the price tag

Valuation

Market Cap
₹806.77 Cr
P/E Ratio
avg33.66
P/B Ratio
watch5.41
EPS
3.12
the engine

Profitability

ROE
good16.08%
ROCE
good48.6%
Net Margin
good23.47%
Op Margin
good34.2%
the trajectory

Growth

EPS YoY
%
Revenue YoY
%
Qtr Sales
good56.2%
Qtr Profit
good53.7%
the balance sheet

Financial Health

Debt / Equity
good0
Book Value
Div Yield
%
Promoter Hold.
good71.29%
Chart Patterns

Gaudium IVF and Women Health Ltd chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for Gaudium IVF and Women Health Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Financials

Gaudium IVF and Women Health Ltd financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Gaudium IVF and Women Health Ltd, switchable between annual and quarterly views, consolidated or standalone.

Gaudium IVF and Women Health Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹806.77 Cr and reported EPS of ₹3.12.

Period2026
Revenue from Operations
104
Other Income
1
Total Income
105
Cost of Goods Sold (COGS)
34
Gross Profit
71
+Operating Expenses
33
EBITDA
38
+Non-Operating Expenses
6
Profit Before Tax (PBT)
32
+Tax Expense
8
Profit/Loss from Discontinued Ops
-0
Total Profit for Period
24
Net Profit (Owner's PAT)
24
Earnings Per Share (EPS)
3.36
Diluted Shares Outstanding (Nos.)
7
+Additional Disclosures
106
Employee Cost %
8
Other Cost %
24
OPM %
36
Tax %
24
Gross Margin %
0.00
EBITDA Margin %
0.00
Interest Coverage Ratio
0.00
+Additional Fields
35
all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Gaudium IVF and Women Health segment analysis: revenue and profit mix.

Disclosed business segments at Gaudium IVF and Women Health with their share of revenue and profit, switchable between consolidated and standalone reporting.

Gaudium IVF and Women Health discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for Gaudium IVF and Women Health Ltd.

Our AI distills the core fundamental drivers supporting Gaudium IVF and Women Health Ltd, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

What can break it.

No weaknesses or threats on record.

flip conditions

What would change my mind.

  • Trim if P/E re-rates above 44. The valuation cushion thins from there.

  • Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.

  • Exit if ROE slips below 11%. The operating engine is no longer compounding capital efficiently.

Shareholding

Gaudium shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Gaudium — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Loading shareholding data...

Peers

Gaudium IVF and Women Health Ltd peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Gaudium IVF and Women Health Ltd is highlighted for quick read-across.

Technicals

Gaudium IVF and Women Health Ltd technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Gaudium IVF and Women Health Ltd — derived from the live tape, not yesterday's close.

Gaudium IVF and Women Health Ltd last traded at ₹128.17 with an intraday range of ₹123.1–₹129.6 — live indicator, pivot and CPR signals below.

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹128.17
LevelPrice (₹)Distance% Δ
R4143.81+15.64+12.21%
R3137.31+9.14+7.13%
R2133.46+5.29+4.12%
R1130.81+2.64+2.06%
PIVOT126.96-1.21-0.95%
CURRENT128.17
S1111.31-16.86-13.15%
S2117.81-10.36-8.08%
S3120.46-7.71-6.02%
S4124.31-3.86-3.01%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 126.35P: 126.96TC: 127.56
R1
R2
R3
R4
indicator
LTP: 128.17
PDH: 133.00
PDL: 118.25
● Market Sentiment

GAUDIUMIVF is trading Above CPR, indicating Bullishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery & Volume

Gaudium IVF and Women Health Ltd delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Gaudium IVF and Women Health Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Gaudium IVF and Women Health Ltd stood at 42.9% of traded volume, against a 20-day average of 40.7%.

Avg Delivery (20D)40.7%+2.2 ppt latest vs avg
Highest Delivery71.5%on 30 Mar
Avg Volume (20D)23.61 L20-day run-rate
Conviction Trend↓ Weakening+2.2 ppt latest read
Volume & Delivery · last 20 sessions
Filings & Concalls

Gaudium IVF and Women Health announcements: results, concalls, ratings, M&A.

Filings Gaudium IVF and Women Health sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

Gaudium IVF and Women Health files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 18 documents below.

  1. 17 Jun 2026Disclosure under SEBI Takeover RegulationsView PDF

    Disclosure under SEBI Takeover Regulations

    Gaudium IVF and Women Health Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board…

  2. 17 Jun 2026Disclosure under SEBI Takeover RegulationsView PDF

    Disclosure under SEBI Takeover Regulations

    Dr. Manika Khanna has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…

  3. 29 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Gaudium IVF and Women Health Limited has informed the Exchange about Link of Recording

  4. 29 May 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    Gaudium IVF and Women Health Limited has informed the Exchange about Newspaper publication of the Audited Financial Results for the quarter and year…

  5. 29 May 2026Investor PresentationView PDF

    Investor Presentation

    Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation

§ 10b · Reports & Decks

Investor decks & rating reports.

Corporate Actions

Gaudium IVF and Women Health dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Gaudium IVF and Women Health has declared, sequenced by announce and record date.

Gaudium IVF and Women Health corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Gaudium IVF and Women Health Ltd: business, sector, key facts.

What Gaudium IVF and Women Health Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Gaudium IVF and Women Health Ltd is a listed Indian equity, listed as NSE: GAUDIUMIVF, BSE: 544709.

GAUDIUMIVF
Listed Equity

Gaudium IVF and Women Health Ltd

company facts
Employees
Sector
Headquarters
Market Cap₹806.77 Cr
Listed OnNSE · BSE
§ ∞ · Plainly Answered

Questions investors ask about Gaudium IVF and Women Health Ltd (GAUDIUMIVF).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Gaudium IVF and Women Health Ltd (GAUDIUMIVF)?

The current share price of Gaudium IVF and Women Health Ltd (GAUDIUMIVF) is ₹128.17. Today, the stock has gained by ₹3.78 (3.04%), trading in a range of ₹123.1 to ₹129.6. The stock opened at ₹127.48 with a trading volume of 11,50,597 shares.

02Is Gaudium IVF and Women Health Ltd stock a good investment for long-term?

Gaudium IVF and Women Health Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹806.77 crores, P/E ratio of 33.66, ROE of 16.08%, and ROCE of 48.60%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Gaudium IVF and Women Health Ltd stock?

The 52-week high price of Gaudium IVF and Women Health Ltd (GAUDIUMIVF) is ₹133, while the 52-week low is ₹69.18. Currently trading at ₹128.17, the stock is 92.4% away from its 52-week low and 3.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Gaudium IVF and Women Health Ltd stock at the current price?

Whether to buy Gaudium IVF and Women Health Ltd stock at ₹128.17 depends on multiple factors. The stock is currently trading with a P/E ratio of 33.66 and P/B ratio of 5.41. Today's performance shows a gain of 3.04%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Gaudium IVF and Women Health Ltd and when is the next dividend?

Gaudium IVF and Women Health Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹128.17, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Gaudium IVF and Women Health Ltd?

Gaudium IVF and Women Health Ltd's key financial metrics include: P/E Ratio: 33.66, P/B Ratio: 5.41, ROE: 16.08%, ROCE: 48.60%, Dividend Yield: 0.00%, EPS: ₹3.12, Book Value: ₹0, and Debt-to-Equity: 0.00. The company's market cap stands at ₹806.77 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Gaudium IVF and Women Health Ltd stock performing today in the market?

Gaudium IVF and Women Health Ltd stock opened at ₹127.48 and is currently trading at ₹128.17, showing a gain of ₹3.78 (3.04%). The intraday high is ₹129.6 and low is ₹123.1. The trading volume stands at 11,50,597 shares, indicating strong market participation today.

08What is the P/E ratio of Gaudium IVF and Women Health Ltd and what does it indicate?

Gaudium IVF and Women Health Ltd has a Price-to-Earnings (P/E) ratio of 33.66, which means investors are willing to pay ₹33.66 for every ₹1 of earnings. With an EPS of ₹3.12, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Gaudium IVF and Women Health Ltd (GAUDIUMIVF) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.